MétaCan
Menu
Back to cohort

Can a New Portable Valved Holding Chamber (VHC) for Use on the Go Improve the Delivery and Reduce Side Effects of a New Combination Albuterol/Budesonide Inhaler?

2025· article· en· W4410268623 on OpenAlexaff
Jason Suggett, JUDY SCHLOSS, Dominic Coppolo, M. Nagel

Bibliographic record

VenueAmerican Journal of Respiratory and Critical Care Medicine · 2025
Typearticle
Languageen
FieldAgricultural and Biological Sciences
TopicPharmacological Effects and Assays
Canadian institutionsTrudell Medical International (Canada)
Fundersnot available
KeywordsMedicineInhalerBudesonideDry-powder inhalerIntensive care medicineAnesthesiaAsthmaInhalationInternal medicine

Abstract

fetched live from OpenAlex

Abstract Rationale: The introduction of a new anti-inflammatory reliever (AIR) inhaler for the combined treatment of symptoms and prevention of bronchoconstriction may trigger changes in current practice. Asthma guidelines recommend that to further optimize MDI drug delivery and minimize potential side effects a valved holding chamber (VHC) / spacer should be used. This laboratory study compared the particle size distribution and potential airway delivery of the combined albuterol/budesonide (AIRSUPRA® (albuterol 90µg/budesonide 80µg)) metered dose inhaler (MDI) when administered alone versus an MDI + a new portable VHC (AeroChamber2go[asterisk], A2GO) and a widely prescribed standard VHC (AeroChamber Plus[asterisk] Flow-Vu[asterisk], ACFV). Methods: Particle size distribution of the active pharmaceutical ingredients (API) within the MDI, both with and without the 2 VHCs, was evaluated. This assessment was conducted using an Andersen Mark II cascade impactor, operating at a flow rate of 28.3 L/min, with five replicate measurements performed for each condition. HPLC was used to quantify the mass of each API in each size fraction. Our analysis focused on the fine particle mass (FPM, <4.7 µm), the portion expected to reach the lungs, and the coarse particle mass (CPM, >4.7 µm), likely to deposit in the upper airways. Results: Data are presented as µg (mean±sd) FPM was similar between the MDI alone and either of the VHCs. Delivery ranged from 30.6-32.8µg/36.9-38.5µg (BUD/ALB) for MDI+VHC to 28.6±1.5µg/34.1±1.7µg for the MDI alone. CPM for BUD was 42.6±1.7µg for the MDI alone and reduced to 8.7-12.0µg with the addition of the VHCs. Conclusion: This study showed that the AeroChamber2go[asterisk] and AeroChamber Plus[asterisk] Flow-Vu[asterisk] VHCs provided similar FPM, compared to the MDI alone. Additionally, the VHCs reduced the CPM associated with oropharyngeal deposition, which could be particularly important with inhaled corticosteroids like budesonide. If deposited in the oropharyngeal region, absorption into the bloodstream increases the potential for systemic side effects. This reduction in upper airway deposition should help lessen concerns about systemic steroid delivery perhaps improving adherence to therapy while lowering the risk of unwanted systemic side effects.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.298
Teacher spread0.272 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAmerican Journal of Respiratory and Critical Care MedicineSame topicPharmacological Effects and AssaysFrench-language works237,207